Gauging the Success of Relapsed-Refractory Hodgkin Lymphoma Treatment

Dr. John Sweetenham, executive medical director at the Huntsman Cancer Institute, discusses the importance of clinic follow-up, regular surveillance and relatively frequent PET scans in gauging the success of a transplant in the treatment of relapsed-refractory Hodgkin’s lymphoma. Patient advocate Meredith Wooten joins the conversation to share how, with the support of her family and friends and her own inner strength, she has coped after her transplant.

Get email alerts | http://www.patientpower.info/

Subscribe on YouTube | http://bit.ly/patientpowerYT
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower